David Goldman

Title: David Goldman - Innovator in Ibuprofen Concentrates

Introduction

David Goldman is a notable inventor based in Glen Arm, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid ibuprofen concentrates. His innovative work has led to the creation of a patented composition that enhances the efficacy of ibuprofen.

Latest Patents

Goldman's most recent patent is titled "Compositions containing solid ibuprofen concentrates and methods of making solid ibuprofen concentrates." This invention focuses on a solid ibuprofen concentrate composition that includes a solid ibuprofen free acid and a solid ibuprofen alkali salt. The composition is characterized by the fact that at least 90% of its weight consists of ibuprofen free acid and ibuprofen alkali salt. This advancement in formulation is expected to improve the delivery and effectiveness of ibuprofen in various applications.

Career Highlights

David Goldman is currently associated with Pharmaceutics International Incorporated, where he applies his expertise in pharmaceutical formulations. His work at the company has been instrumental in advancing the development of innovative drug delivery systems. With a patent portfolio that includes 1 patent, Goldman continues to contribute to the pharmaceutical industry.

Collaborations

Goldman collaborates with talented professionals such as Emadeldin Hassan and Sridhar Gumudavelli. Their combined efforts in research and development have fostered a collaborative environment that encourages innovation and excellence in pharmaceutical sciences.

Conclusion

David Goldman is a prominent figure in the field of pharmaceutical innovation, particularly known for his work on solid ibuprofen concentrates. His contributions have the potential to significantly impact the effectiveness of pain management therapies.